JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

Search

ResMed Inc

Cerrado

SectorSanidad

222.12 1.1

Resumen

Variación precio

24h

Actual

Mínimo

219.17

Máximo

223.9

Métricas clave

By Trading Economics

Ingresos

44M

393M

Ventas

87M

1.4B

P/B

Media del Sector

22.368

60.328

Rentabilidad por dividendo

0.99

Margen de beneficios

27.593

Empleados

10,600

EBITDA

63M

566M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+29.86% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.99%

2.24%

Próximas Ganancias

30 abr 2026

Fecha Próximo Dividendo

11 jun 2026

Próxima Fecha de Ex Dividendo

7 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-4.3B

33B

Apertura anterior

221.02

Cierre anterior

222.12

Noticias sobre sentimiento de mercado

By Acuity

10%

90%

12 / 348 Clasificación en Healthcare

ResMed Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 abr 2026, 23:15 UTC

Noticias de Eventos Importantes

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 abr 2026, 23:08 UTC

Ganancias
Principales Movimientos del Mercado

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 abr 2026, 23:58 UTC

Ganancias

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 abr 2026, 23:58 UTC

Ganancias

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 abr 2026, 23:56 UTC

Ganancias

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 abr 2026, 23:56 UTC

Ganancias

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 abr 2026, 23:48 UTC

Charlas de Mercado

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 abr 2026, 23:42 UTC

Charlas de Mercado

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 abr 2026, 23:34 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 abr 2026, 23:30 UTC

Charlas de Mercado

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 abr 2026, 23:08 UTC

Charlas de Mercado

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 abr 2026, 23:02 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 abr 2026, 23:02 UTC

Charlas de Mercado

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 abr 2026, 22:42 UTC

Charlas de Mercado

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 abr 2026, 22:10 UTC

Ganancias

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 abr 2026, 22:09 UTC

Ganancias

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 abr 2026, 22:09 UTC

Ganancias

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 abr 2026, 22:09 UTC

Ganancias

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 abr 2026, 21:56 UTC

Ganancias

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 abr 2026, 21:55 UTC

Ganancias

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 abr 2026, 21:55 UTC

Ganancias

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 abr 2026, 21:44 UTC

Ganancias

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 abr 2026, 21:43 UTC

Ganancias

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 abr 2026, 21:41 UTC

Ganancias

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 abr 2026, 21:41 UTC

Ganancias

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 abr 2026, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

27 abr 2026, 20:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

27 abr 2026, 20:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Financial Services Roundup: Market Talk

27 abr 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

27 abr 2026, 20:39 UTC

Ganancias

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Comparación entre iguales

Cambio de precio

ResMed Inc previsión

Precio Objetivo

By TipRanks

29.86% repunte

Estimación a 12 Meses

Media 285.5 USD  29.86%

Máximo 340 USD

Mínimo 255 USD

De acuerdo con 13 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para ResMed Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

13 ratings

8

Comprar

5

Mantener

0

Vender

Sentimiento

By Acuity

12 / 348 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat